Xiaoling Weng

1.9k total citations
31 papers, 696 citations indexed

About

Xiaoling Weng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaoling Weng has authored 31 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Xiaoling Weng's work include Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer-related gene regulation (5 papers). Xiaoling Weng is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer-related gene regulation (5 papers). Xiaoling Weng collaborates with scholars based in China, United States and South Korea. Xiaoling Weng's co-authors include Fatao Liu, Junyi Ye, Daizhan Zhou, Yun Liu, Lin He, Hong Zhang, Mengyuan Kan, Lidan Hou, Xiangjun Meng and Zhaoyuan Hou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoling Weng

31 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Weng China 16 382 187 160 91 83 31 696
Saioa Goñi Spain 16 504 1.3× 171 0.9× 156 1.0× 68 0.7× 116 1.4× 28 900
Petra Kleiblová Czechia 18 463 1.2× 199 1.1× 323 2.0× 79 0.9× 44 0.5× 47 1.0k
Agata Filip Poland 17 319 0.8× 175 0.9× 160 1.0× 101 1.1× 67 0.8× 67 751
Christopher G. Fenton Norway 16 334 0.9× 176 0.9× 183 1.1× 73 0.8× 66 0.8× 30 814
Alexander M. Tseng United States 15 579 1.5× 267 1.4× 125 0.8× 57 0.6× 86 1.0× 27 946
Anita Chudecka-Głaz Poland 17 227 0.6× 155 0.8× 232 1.4× 51 0.6× 98 1.2× 85 863
William Puszyk United States 15 421 1.1× 133 0.7× 92 0.6× 40 0.4× 49 0.6× 20 683
Tomoyo Yasui Japan 15 263 0.7× 156 0.8× 202 1.3× 72 0.8× 75 0.9× 58 637
Rachel A. Egler United States 14 397 1.0× 101 0.5× 152 0.9× 72 0.8× 211 2.5× 25 907

Countries citing papers authored by Xiaoling Weng

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Weng more than expected).

Fields of papers citing papers by Xiaoling Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Weng. The network helps show where Xiaoling Weng may publish in the future.

Co-authorship network of co-authors of Xiaoling Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Weng. A scholar is included among the top collaborators of Xiaoling Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Weng. Xiaoling Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tian, Feng, Xiaoling Weng, Nanhui Yu, et al.. (2024). IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth. Oncogene. 43(49). 3598–3616. 3 indexed citations
3.
Li, Guoqiang, Peng Pu, Mengqiao Pan, et al.. (2023). Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer. Frontiers of Medicine. 18(1). 109–127. 3 indexed citations
4.
Deng, Jiaying, et al.. (2022). A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients. Translational Cancer Research. 11(9). 3128–3140. 5 indexed citations
5.
Zhang, Jieyun, Fatao Liu, Yanan Yang, et al.. (2022). Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer. Cell Death and Disease. 13(4). 392–392. 15 indexed citations
6.
8.
Deng, Jiaying, Xiaoling Weng, Junyi Ye, et al.. (2019). Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing. Frontiers in Genetics. 10. 47–47. 12 indexed citations
9.
Weng, Xiaoling, Fatao Liu, Hong Zhang, et al.. (2018). Genome-wide DNA methylation profiling in infants born to gestational diabetes mellitus. Diabetes Research and Clinical Practice. 142. 10–18. 50 indexed citations
10.
Zhang, Yihong, Wenli Qian, Xiaoling Weng, et al.. (2018). Enhanced PAPSS2/VCAN sulfation axis is essential for Snail-mediated breast cancer cell migration and metastasis. Cell Death and Differentiation. 26(3). 565–579. 86 indexed citations
11.
Li, Yue, Mengfei Yao, Tianqi Wu, et al.. (2018). Loss of hypermethylated in cancer 1 (HIC1) promotes lung cancer progression. Cellular Signalling. 53. 162–169. 8 indexed citations
12.
Niu, Xiaomin, Fatao Liu, Yi Zhou, et al.. (2017). Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment. Clinical Cancer Research. 23(17). 5003–5014. 16 indexed citations
13.
Hao, Mingang, Xiaoling Weng, Yingying Wang, et al.. (2017). Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy. Biochemical Pharmacology. 147. 128–140. 19 indexed citations
14.
Hou, Lidan, Danxi Zhu, Yu Liang, et al.. (2017). Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library. British Journal of Cancer. 118(1). 79–87. 17 indexed citations
15.
Weng, Xiaoling, Hong Zhang, Junyi Ye, et al.. (2015). Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer. Scientific Reports. 5(1). 10154–10154. 20 indexed citations
16.
Zhang, Hong, Xiaoling Weng, Junyi Ye, et al.. (2015). Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population. Clinics and Research in Hepatology and Gastroenterology. 39(5). 600–609. 30 indexed citations
17.
Weng, Xiaoling, Daizhan Zhou, Fatao Liu, et al.. (2014). DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiation. BMC Neuroscience. 15(1). 31–31. 7 indexed citations
18.
Liu, Yun, Lan Cao, Zhiqiang Li, et al.. (2014). A Genome-Wide Association Study Identifies a Locus on TERT for Mean Telomere Length in Han Chinese. PLoS ONE. 9(1). e85043–e85043. 35 indexed citations
19.
Hu, Wensheng, Xiaoling Weng, Minyue Dong, et al.. (2014). Alteration in methylation level at 11β-hydroxysteroid dehydrogenase type 2 gene promoter in infants born to preeclamptic women. BMC Genetics. 15(1). 96–96. 18 indexed citations
20.
Wang, Wei, Xiaotian Sun, Xiaoling Weng, et al.. (2013). Comprehensive screening for PRSS1, SPINK1, CFTR, CTRC and CLDN2 gene mutations in Chinese paediatric patients with idiopathic chronic pancreatitis: a cohort study. BMJ Open. 3(9). e003150–e003150. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026